Assembly Biosciences, Inc. Up to $75,000,000 of Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • December 29th, 2017 • Assembly Biosciences, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 29th, 2017 Company Industry JurisdictionAssembly Biosciences, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: